KZA 5.26% 63.0¢ kazia therapeutics limited

*** alert: massive news ***

  1. 3,567 Posts.
    Yale Researchers Discover That Phenoxodiol Combined With Small Doses Of Chemotherapy Reduces Ovarian Cancer Tumor Mass By 75 Percent; Data Presented Today at ASCO

    This is certainly excellent news:

    "While cisplatin alone had no effect on tumor size, the combination of phenoxodiol (10mg/kg) and cisplatin (0.5mg/kg) reduced tumor mass by 75 percent."

    ""Phenoxodiol represents the next generation of anti-cancer drugs -- it appears to work on multiple pathways to induce cancer cells to self destruct while having no meaningful toxicity on healthy cells," said Steven Knapp, portfolio manager, Simba Management Group. "Phenoxodiol appears to be the first drug to specifically hit a target that is only present on cancer cells. FDA's apparent commitment to getting promising cancer drugs to late stage cancer patients combined with phenoxodiol's safety profile and early indications of clinical success convinces me that phenoxodiol's path to the market has been accelerated."


watchlist Created with Sketch. Add KZA (ASX) to my watchlist
(20min delay)
Mkt cap ! $47.99M
Open High Low Value Volume
64.0¢ 64.0¢ 63.0¢ $39.78K 62.34K

Buyers (Bids)

No. Vol. Price($)
1 11093 64.0¢

Sellers (Offers)

Price($) Vol. No.
65.0¢ 1800 1
View Market Depth
Last trade - 13.32pm 12/12/2019 (20 minute delay) ?
-0.035 ( 0.00 %)
Open High Low Volume
64.0¢ 64.0¢ 63.0¢ 23785
Last updated 13.32pm 12/12/2019 (live) ?
KZA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.